This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
EnglishDeutsch
de
EnglishDeutsch
de
Login Environment Pharma

Diagnosis of microscopic disease from tissue cuttings - your specialist in histopathology

SYNLAB pharma employs experienced pathologists able to flexibly adapt their reading approach to any international classification or standard procedures required by the Sponsor.

Results are coded to avoid the use of 'free text' and ease statistical evaluation. Reports can be printed in English or German. Long-term storage of paraffin blocks and slides is available.

Regulatory authorities such as the FDA require that a second, independent pathologist reviews all tissue materials in a blinded manner. SYNLAB pharma has implemented this requirement and offers a number of independent experts to be used as referees or arbitrators in the event that pathologists' evaluations differ.

With our visit-specific kits, specific UN-approved containers with buffered formalin can be provided for biopsy transportation.

Contact us



News & Events

View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

pharma@synlab.com

Jun 18, 2018 | Pharma Continue
View All